Lessons From LEADER – All-round Leadership

The large multinational, randomised, double-blind LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation) trial recently reported the cardiovascular (CV) benefits achieved with liraglutide therapy in type 2 diabetes mellitus (T2DM). T...

Descripción completa

Detalles Bibliográficos
Autor principal: Kalra, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2016
Materias:
Editorial Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813445/
https://www.ncbi.nlm.nih.gov/pubmed/29632591
http://dx.doi.org/10.17925/EE.2016.12.02.76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813445/
https://www.ncbi.nlm.nih.gov/pubmed/29632591
http://dx.doi.org/10.17925/EE.2016.12.02.76

Ejemplares similares